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Abstract. 
 
Reversible phosphorylation plays an impor-
tant role in pre-mRNA splicing in mammalian cells. 
Two kinases, SR protein-specific kinase (SRPK1) and 
Clk/Sty, have been shown to phosphorylate the SR 
family of splicing factors. We report here the cloning 
and characterization of SRPK2, which is highly related 
to SRPK1 in sequence, kinase activity, and substrate 
specificity. Random peptide selection for preferred 
phosphorylation sites revealed a stringent preference of 
SRPK2 for SR dipeptides, and the consensus derived 
may be used to predict potential phosphorylation sites 
in candidate arginine and serine-rich (RS) domain–con-
taining proteins. Phosphorylation of an SR protein 
(ASF/SF2) by either SRPK1 or 2 enhanced its interac-
tion with another RS domain–containing protein (U1 
70K), and overexpression of either kinase induced spe-
cific redistribution of splicing factors in the nucleus. 
These observations likely reflect the function of the 
SRPK family of kinases in spliceosome assembly and in 
mediating the trafficking of splicing factors in mamma-
lian cells. The biochemical and functional similarities 
between SRPK1 and 2, however, are in contrast to their 
differences in expression. SRPK1 is highly expressed in 
pancreas, whereas SRPK2 is highly expressed in brain, 
although both are coexpressed in other human tissues 
and in many experimental cell lines. Interestingly, 
 
SRPK2 also contains a proline-rich sequence at its NH
 
2
 
 
terminus, and a recent study showed that this NH
 
2
 
-ter-
minal sequence has the capacity to interact with a WW 
domain protein in vitro. Together, our studies suggest 
that different SRPK family members may be uniquely 
regulated and targeted, thereby contributing to splicing 
regulation in different tissues, during development, or 
in response to signaling.
 
P
 
re-mRNA 
 
splicing in mammalian cells takes place in
a multi-component complex known as the spliceo-
some, which contains two classes of splicing factors:
U1, U2, U5, and U4/6 small nuclear ribonucleoprotein
particles (snRNPs)
 
1
 
 and non-snRNP splicing factors (for
review see Krämer, 1996). A series of interactions be-
tween pre-mRNA and snRNPs during spliceosome assem-
bly are critical for splice-site selection, and most impor-
tantly, for establishing a catalytic core for the splicing
reaction to occur in the spliceosome. However, most of
these interactions are mediated by non-snRNP factors.
Among the best characterized non-snRNP factors are the
superfamily of arginine/serine-rich (RS) domain-contain-
ing splicing factors (for review see Fu, 1995). The family is
composed of “classic” SR proteins that are characterized
by one or two RNA recognition motifs at the NH
 
2
 
 termi-
nus, an RS domain at the COOH terminus, and other RS
domain–containing polypeptides. RNA recognition motifs
are responsible for binding to RNA, whereas RS domains
appear to function as protein–protein interaction modules
to mediate various spliceosome assembly steps. Thus,
some RS domain–containing proteins may mediate com-
plex assembly on RNA, whereas others may function as
adaptor molecules to bring complexes together in spliceo-
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some assembly. Because RS domain–containing proteins
play a critical role in selecting and pairing functional splice
sites, many splicing factors in this family are not only es-
sential for constitutive splicing, but can also affect alterna-
tive splicing (for review see Fu, 1995; Manley and Tacke,
1996; Valcárcel and Green, 1996).
All RS domain–containing proteins are probably post-
translationally modified by phosphorylation, and revers-
ible phosphorylation has been shown to play an important
role in splicing. For example, no splicing complexes could
be detected in nuclear extract treated with the phos-
phatase PP1, indicating that phosphorylation is essential
for early steps of spliceosome assembly, and SR proteins
appear to be the major targets of the PP1 treatment (Mer-
moud et al., 1994). Consistent with these findings, phos-
phorylation was recently shown to promote specific pro-
tein–protein interactions between U1 70K and ASF/SF2,
both of which contain an RS domain (Xiao and Manley,
1997). On the other hand, dephosphorylation is critical for
splicing after spliceosome assembly. When nuclear ex-
tracts were treated with phosphatase inhibitors, spliceo-
some assembly was not affected, but splicing was blocked.
Splicing in the stalled spliceosome could then be rescued
by phosphatase PP1 or PP2A (Mermoud et al., 1992).
Moreover, incorporation of nonhydrolyzable 
 
g
 
-S-ATP in
the RS domain–containing U1 70K blocked splicing after
spliceosome assembly (Tazi et al., 1993). Together, these
studies strongly indicate that a phosphorylation–dephos-
phorylation cycle is important for RNA splicing. Addition-
ally, PP1 was also shown to affect splice-site selection in
vitro (Cardinal et al., 1994). Because SR proteins are
known to affect splice-site selection both in vitro and in
vivo, and PP1 clearly caused dephosphorylation of these
splicing factors in nuclear extract, it is likely that the PP1
effect on alternative splicing is mediated through changes
in the phosphorylation state of SR proteins (Mermoud et al.,
1994).
Two families of kinases, SR protein-specific kinase
(SRPK) and Clk/Sty, have been identified that phosphory-
late RS domain–containing splicing factors. Our lab identi-
fied and cloned human SRPK1 in the pursuit of an activity
that mediates splicing factor redistribution in the cell cycle
(Gui et al., 1994
 
a
 
). SRPK1 is a kinase highly specific for
RS domain–containing splicing factors because it recog-
nizes only arginine (not lysine) and phosphorylates only
serine (not threonine) in its substrates (Gui et al., 1994
 
b
 
).
Clk/Sty was initially cloned as a cdk-like kinase by PCR
(Johnson and Smith, 1991; Ben-David et al., 1991) as well
as a dual specificity kinase in an expression screening
(Howell et al., 1991). In fact, three highly related Clk/Sty
kinases are expressed in mammalian cells (Hanes et al.,
1994). Clk/Sty was later found to interact with RS domain–
containing splicing factors in the yeast two-hybrid system,
and to efficiently phosphorylate these splicing factors in
vitro (Colwill et al., 1996
 
a
 
). Interestingly, Clk/Sty itself
contains several SR or RS repeats at the NH
 
2
 
 terminus,
which appear to contribute to its high affinity binding with
RS domain–containing substrates. SRPK1 and Clk/Sty
share 32% identity in their kinase domains and both con-
tain a signature amino acid sequence referred to as the
LAMMER motif (Colwill et al., 1996
 
a
 
). A systematic com-
parison between the two kinases revealed that SRPK1 dis-
 
plays high specific activity towards RS domain–containing
splicing factors, whereas Clk/Sty has broader substrate
specificity (Colwill et al., 1996
 
b
 
). These observations sug-
gest that these two kinases may have distinct functions in
pre-mRNA splicing. Clearly, splicing is likely to be regu-
lated by multiple kinases and phosphatases, given the
complexity of the splicing reaction and the diversity of
splicing factors involved.
In this paper, we report the cloning and characterization
of a new SRPK family member named SRPK2 that was
discovered based on its sequence similarity to SRPK1.
A series of biochemical experiments demonstrate that
SRPK1 and 2 are very similar with respect to their enzy-
matic activity and substrate specificity. Both kinases pro-
moted specific protein–protein interactions between RS
domain–containing splicing factors and their overexpres-
sion induced the redistribution of splicing factors from nu-
clear speckles to nucleoplasm, indicating that both kinases
may be involved in the regulation of spliceosome assembly
in vivo. However, these two kinases are differentially ex-
pressed in various human tissues and each kinase contains
unique sequence features that may contribute to their spe-
cific function and/or regulation in vivo. Therefore, mam-
malian cells may have evolved multiple kinases to regulate
RNA splicing, and these SR protein kinases may them-
selves be targets for regulation.
 
Materials and Methods
 
cDNA Cloning of SRPK2
 
A database search revealed multiple expression seqence tag (EST) clones
that are homologous but not identical to SRPK1. One such cDNA clone
(Genbank/EMBL/DDBJ accession number H00135) was obtained from
Research Genetics, Inc. (Huntsville, AL), and sequencing analysis showed
that the clone encodes a serine/threonine kinase and displays 78% identity
to SRPK1 in their kinase domains. DNA probes derived from the clone
were used to screen a human fetal brain cDNA library in the Lambda
ZAP II vector (Stratagene, La Jolla, CA). From 5 
 
3
 
 10
 
5
 
 plaques, 31 posi-
tive clones were obtained. Restriction analysis showed that all the clones
are derived from different regions of a single cDNA, and thus, the longest
clone was sequenced in both strands.
 
Expression of SRPK2 and Its Substrates
 
The HpaI–NheI fragment encoding the full-length SRPK2 was cloned into
the pAcG2T vector (PharMingen, San Diego, CA) to express the kinase
as a glutathione-S-transferase (GST) fusion protein by baculovirus ac-
cording to manufacturer’s instructions. GST-SRPK2 was purified on glu-
tathione-Sepharose 4B beads (Pharmacia Biotechnology Inc., Piscataway,
NJ). ASF/SF2 and its mutant derivatives were expressed and purified
from bacteria (Gui et al., 1994
 
b
 
; Colwill et al., 1996
 
b
 
). GST-ASF/SF2 and
U2AF65 were also made in bacteria. Other RS domain–containing pro-
teins (SRp20, GST-SRp40, GST-SC35, SRp55) were expressed by bacu-
lovirus as described (Gui et al., 1994
 
a
 
).
 
Northern Blotting Analysis
 
A human multiple tissue Northern blot was purchased from Clontech
Laboratories Inc. (Palo Alto, CA). Soas2, HBL100, Bosc23, SF763,
MG63, and Hela cells were cultured in DME (Life Technologies, Gaith-
ersburg, MD) plus 10% heat-inactivated FCS (Hyclone, Logan, UT).
Lan5 cells were grown in DME-F12 plus 10% FCS. THP1, U937, Weri1,
and Lnz308 cells were cultured in RPMI 1640 (Irvine Scientific, Santa
Ana, CA) plus 10% FCS. Total RNA from 6 
 
3
 
 10
 
5
 
 cultured cells was ex-
tracted using RNAexol (BioChain, San Leandro, CA); 15–20 
 
m
 
g of total
RNA was separated in 1% agarose gel containing 2.2 M formaldehyde
and then blotted onto Hybond-N
 
1
 
 nylon membrane (Amersham Corp.,
Arlington Heights, IL). After baking the membrane at 80
 
8
 
C for 2 h, the 
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membrane was stained with methylene blue to visualize RNA molecular
markers (Life Technologies) and destained in H
 
2
 
O. The blots were prehy-
bridized at 68
 
8
 
C for 1 h in 10 ml ExpressHyb Hybridization solution
(Clontech Laboratories Inc.), and then hybridized with random primed
probes as specified in Fig. 8. After hybridization for 1–2 h, the blots were
washed at 50
 
8
 
C for 15 min sequentially in 0.1% SDS plus 0.5, 0.25, and
0.1
 
3
 
 SSC before exposure to X-ray film. For normalization, each blot was
stripped by boiling in 0.5% SDS for 5 min and reprobed for glyceralde-
hyde-3-phosphate dehydrogenase.
 
In Vitro Kinase Assay
 
The kinase activity of purified SRPK1 and 2 was normalized using bacte-
rial ASF/SF2 as a substrate and then used to phosphorylate other sub-
strates as described (Gui et al., 1994
 
b
 
). Each purified substrate was nor-
malized (using BSA as a standard) to 0.1 
 
m
 
g for testing phosphorylation in
Fig. 2 
 
B
 
 or to 1 
 
m
 
g in Fig. 2 
 
C.
 
 To determine whether bacterial ASF/SF2
could gain the mAb104 phosphoepitope upon phosphorylation by
SRPK2, 0.1 
 
m
 
g of GST-ASF/SF2 was incubated with purified SRPK2 in
the presence of 1 mM ATP under kinase assay conditions followed by
Western blotting with mAb104 (culture supernatant). The blot was devel-
oped by enhanced chemiluminescence (ECL; Pierce, Rockford, IL). To
compare the relative specific activities of SRPK1 and 2, full-length SRPK1
and 2 cDNAs were fused with a FLAG-tag sequence at their NH
 
2
 
 termini,
and cloned into the pSP73 vector for in vitro transcription/translation in
the TNT system (Promega Corp., Madison, WI). The translated products
were immunoprecipitated using the M2 anti-FLAG monoclonal antibody
followed by a kinase assay on beads as previously described (Colwill et al.,
1996
 
b
 
). After SDS-PAGE, 
 
35
 
S-labeled kinases and 
 
32
 
P-labeled ASF/SF2
were quantitated by phosphoimaging (Molecular Dynamics Inc., Sunny-
vale, CA).
 
Determination of Phosphorylation Consensus by 
Peptide Selection
 
Rationale for peptide library design and synthesis were as previously de-
scribed (Songyang et al., 1994). In the current study, a serine-oriented and
arginine-directed peptide library (see Fig. 4 
 
A
 
) was used. For the kinase
reaction, purified SRPK2 (100 U, as defined in Gui et al., 1994
 
a
 
) was incu-
bated at 25
 
8
 
C for 1 h with 1 mg of degenerate peptide mixture in a 300-
 
m
 
l
reaction volume in the presence of 100 mM ATP, trace labeled with [
 
g
 
-
 
32
 
P]ATP (
 
z
 
6 
 
3
 
 10
 
5
 
 cpm), 1 mM DTT, 10 mM MgCl
 
2
 
, and 50 mM Tris, pH
7.5. After the reaction, free ATP was removed by DEAE-Sephacel chro-
matography, and phosphopeptides were quantitatively separated from the
unphosphorylated mixture on a ferric chelation column as previously de-
scribed (Songyang et al., 1994). Peptide sequencing and data analysis were
also as described (Songyang et al., 1994).
 
Protein–Protein Interaction Determined by the GST 
Pulldown Assay
 
The assay was performed essentially as described (Xiao and Manley,
1997). Bacterially expressed GST-ASF/SF2 was kinased in vitro by bacu-
lovirus-expressed GST-SRPK1 or 2 as described (Gui et al., 1994
 
b
 
), ex-
cept that the ATP concentration was raised to 1 mM, and the reaction was
incubated at 30
 
8
 
C for 4 h. Unphosphorylated GST-ASF/SF2 was prepared
in a parallel sample lacking ATP. Treated proteins were desalted on G25
columns equilibrated in NETN (20 mM Tris-Cl, pH 8.0, 100 mM NaCl,
0.5 mM EDTA, 0.5% NP-40; Xiao and Manley, 1997), and rebound to glu-
tathione-Sepharose. Beads were washed twice with NETN containing 1 M
NaCl, and then three times with NETN. Bead aliquots containing 1–2 
 
m
 
g
GST or GST-ASF/SF2 were incubated in 200 
 
m
 
l NETN with 3 
 
m
 
l in vitro
translated [
 
35
 
S]methionine U1 70K for 30 min at 4
 
8
 
C. Beads were washed
three times in NETN, treated with RNase and washed once, and then
boiled in SDS-PAGE sample buffer. After SDS-PAGE, U1 70K was de-
tected by autoradiography.
 
Indirect Immunofluorescence Microscopy
 
Full-length SRPK2 (the HpaI–NheI fragment) was subcloned into the
NcoI–XbaI sites in the pUHD10-3 vector to create pUHD–SRPK2, in
which a FLAG tag was fused with SRPK2 at its NH
 
2
 
 terminus. This vector
system is used in cells expressing a tetracycline-controlled transactivator
(tTA), and thus, gene expression is constitutive in the absence of tetracy-
cline (Gossen and Bujard, 1992). 1 d before transfection, 5 
 
3
 
 10
 
4
 
 tTA
HeLa cells were seeded in 6-cm plates containing two or three 1.8-cm
round coverslips coated with 0.1% gelatin. 10 
 
m
 
g of pUHD-SRPK2 plas-
mid DNA was transfected per plate by the calcium–phosphate method
and the transfected cells were washed three times with PBS 16–24 h later.
After culturing in fresh medium for another 16–24 h, cells were processed
for immunostaining at room temperature as described (Fu and Maniatis,
1990). Briefly, cells were washed twice in PBS, and then fixed in 2% form-
aldehyde plus 0.2% Triton X-100 for 10 min. Fixed cells were perme-
ablized in 1% Triton X-100 for 10 min, washed three times in PBS, and
then blocked for 30 min in 20% FBS plus 0.5% Tween 20. Cells were
stained for 1 h with the primary monoclonal M2 anti-FLAG (IgG1; 1:1,200
dilution from the 2 mg/ml stock purchased from Eastman Kodak Co.
(Rochester, NY) and B1C8 (IgM; 1:50 dilution from culture supernatant; a
gift from B. Blencowe and P. Sharp, Massachusetts Institute of Technol-
ogy, Cambridge, MA) or mAb104 (IgM; undiluted culture supernatant),
washed three times with PBS plus 0.1% NP-40, and developed for 1 h with
secondary rhodamine-conjugated goat anti–mouse IgG and FITC-conju-
gated goat anti–mouse IgM (Southern Biotechnology, Birmingham, AL).
Finally, the coverslips were mounted in an antiquenching solution (25 mg/
ml 1,4-diazabicyclo [2.2.2] octane and 70% glycerol in PBS) for examina-
tion under a Zeiss Axiophot fluorescence microscope.
 
Results
 
Identification and Cloning of SRPK2
 
We previously described the cloning and characterization
of SRPK1, a serine kinase highly specific for the RS do-
main present in many splicing factors (Gui et al., 1994
 
a
 
,
 
b
 
;
Colwill et al., 1996
 
b
 
). To gain further understanding of its
biological functions, we conducted chromosomal mapping.
Unexpectedly, probes derived from SRPK1 hit multiple
loci in both mice and humans (our unpublished results),
suggesting the possibility of multiple related kinases.
These observations prompted us to search for SRPK1-
related expression sequence tags in databases. We found
eight clones displaying extensive homology to various re-
gions within the kinase domain of SRPK1. Sequencing
analysis revealed two kinases, one of which is SRPK1 and
the other (represented by the clone H00135) is highly re-
lated, but not identical to SRPK1. We then screened a hu-
man fetal brain cDNA library using probes derived from
H00135 and isolated a full-length clone, which contains an
open reading frame encoding a novel kinase of 686 amino
acids (Fig. 1 
 
A
 
).
Sequence comparison with SRPK1 revealed several fea-
tures of this new kinase: first, the new kinase displays 77%
identity and 90% similarity to SRPK1 over their entire ki-
nase domains (kinase domains are boxed in Fig. 1 
 
A
 
, and
individual domains are underlined and marked in Fig. 1 
 
B
 
).
Second, like SRPK1, the kinase domains of this new ki-
nase are divided into two halves by a large spacer se-
quence (Fig. 1), a structural feature rare among serine/
threonine kinases, but common among tyrosine kinases
(Hanks and Quinn, 1991). Interestingly, one-third of the
spacer region is also highly conserved between the two ki-
nases (Fig. 1 
 
B
 
). Comparison with cAMP-dependent pro-
tein kinase A (PKA; Fig. 1 
 
B
 
) indicates that the spacers
are inserted between two 
 
b
 
 sheets (
 
b
 
8 and 
 
b
 
9; Taylor and
Radzio-Andzelm, 1994), suggesting that the spacers may
function as an autonomous domain in these kinases (see
below). Third, both SRPK1 and the new kinase have a
small deletion between kinase domain II and III, and a
small insertion in the linker loop within kinase domain V
(Fig. 1 
 
B
 
). These differences may contribute significantly 
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to the activity and specificity of these kinases (see Discus-
sion for further details). Based on these structural similari-
ties as well as on many shared biochemical properties with
SRPK1 described below, we named the new kinase SRPK2.
SRPK2 also contains unique features that may be indic-
ative of its function and/or regulation in vivo. Most nota-
bly, SRPK2 contains a proline-rich sequence APLVPPPP-
PPPPPPPPPLPDPTPPEP at the NH
 
2
 
 terminus (underlined
in Fig. 1 
 
A
 
). This motif contains the binding consensus
core for Src Homology 3 (SH3) domain–containing pro-
teins (PXXP, X-any amino acid, P-proline; Ren et al., 1993),
and for a subclass of WW domain–containing proteins that
bind to proteins containing PPLP cores (underlined above)
usually in the context of polyprolines (Chan et al., 1996;
Sudol, 1996
 
a
 
; Bedford et al., 1997). Indeed, a recent two-
hybrid screen using a WW domain–containing protein as
bait identified a mouse cDNA fragment, WBP6, which is
highly homologous to SRPK2 (Bedford et al., 1997; see
Discussion). Accordingly, this NH
 
2
 
-terminal proline–rich
motif of SRPK2 may function as a targeting signal to inter-
act with substrates and/or regulators.
 
SRPK2 Is Specific for RS Domain–containing
Splicing Factors
 
The extensive sequence homology between SRPK1 and 2
Figure 1. Sequence of SRPK2. (A) Nucle-
otide and deduced amino acid sequences of
SRPK2 (GenBank/EMBL/DDBJ accession
number U88666). Underlined is a proline-rich
sequence and boxed are kinase catalytic do-
mains. (B) Sequence comparison with SRPK1
and PKA. Kinase domains are underlined
and marked according to Hanks and Quinn
(1991). Identical amino acids between SRPK1
and 2 and conserved amino acids in PKA are
in bold. Gaps (indicated by dashes) were in-
troduced to optimize the alignment. Amino
acids that form the P11 pocket are numbered
according to the PKA nomenclature. Func-
tional loops are highlighted in black boxes.
An asterisk indicates Thr197 in PKA and the
corresponding amino acids in SRPK1 and 2,
and diamonds label the amino acids that form
ion pairs with Thr197 in PKA tertiary struc-
ture as previously described (Taylor and
Radzio-Andzelm, 1994). 
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suggests that they may have similar enzymatic activity and
substrate specificity. To test this possibility, we prepared
both kinases by in vitro transcription/translation followed
by immunoprecipitation, and SR protein-kinase activity
was assayed on beads using bacterially expressed ASF/SF2
as substrate. As shown in Fig. 2 
 
A
 
, both SRPK1 and 2
phosphorylated ASF/SF2 with a similar specific activity,
demonstrating that SRPK2 is an active kinase for this SR
protein. We then tested phosphorylation of other RS do-
main–containing splicing factors using purified baculovi-
rus-expressed SRPK2. As shown in Fig. 2 
 
B
 
, SRPK2 effi-
ciently phosphorylated SRp20, ASF/SF2, SC35, SRp40,
and SRp55, as well as U2AF65. SRPK2 could not phos-
phorylate other common kinase substrates such as histone
H1 or myelin basic protein (data not shown). Therefore,
like SRPK1, SRPK2 is specific for RS domain–containing
splicing factors.
To determine whether SRPK2-mediated phosphoryla-
tion took place in the RS domain and to further character-
ize the sequence requirement for SRPK2-mediated phos-
phorylation, we tested phosphorylation of a panel of ASF/
SF2 mutants. Previous studies demonstrate that, although
both SRPK1 and Clk/Sty phosphorylate this splicing factor
in its RS domain, they have different sequence require-
ments (Colwill et al., 1996
 
b
 
). For example, changing
serines to threonines in all RS dipeptides in ASF/SF2 abol-
ished phosphorylation by both kinases, indicating that
both proteins are serine-specific kinases. However, chang-
ing arginines to lysines abolished phosphorylation by
SRPK1, but had little effect on phosphorylation by Clk/
Sty, indicating that SRPK1, but not Clk/Sty, requires argi-
nine for substrate recognition and phosphorylation. As
shown in Fig. 2 
 
C
 
, SRPK2-mediated phosphorylation of
ASF/SF2 was abolished when the RS domain was deleted
(
 
D
 
RS), showing that phosphorylation occurs in this do-
main. Replacing serines by threonines (RT) or glycines
(RG) in all RS dipeptides in ASF/SF2 diminished phos-
phorylation (some residual phosphorylation likely takes
place at unmutagenized serines outside the RS repeats; Gui
et al., 1994
 
b
 
), and mutation of arginines in the RS dipep-
tides, KS and GS, resulted in a complete loss of phosphor-
ylation of ASF/SF2 by SRPK2. Therefore, SRPK2 has the
same substrate specificity as SRPK1, displaying a stringent
requirement for both arginine and serine in phosphorylat-
ing RS domain–containing splicing factors.
Previous studies also showed that a specific phosphory-
lated epitope is present in all standard SR proteins purified
from mammalian cells and is recognized by the mono-
clonal antibody mAb104 (Zahler et al., 1992). This phos-
phoepitope can be restored to bacterially expressed ASF/
SF2 by both SRPK1- and Clk/Sty-mediated phosphoryla-
tion (Gui et al., 1994
 
b
 
; Colwill et al., 1996
 
b
 
). To verify if
this is also true for SRPK2, bacterially expressed GST-
ASF/SF2 was phosphorylated by SRPK2 and analyzed by
Western blotting using mAb104. Fig. 2 
 
D
 
 shows that ASF/
SF2 did regain the mAb104 specific phosphoepitope upon
phosphorylation by SRPK2, and the phosphorylation was
also accompanied by a mobility shift in SDS-PAGE as ex-
pected (data not shown, see Fig. 5 
 
A
 
). Taken together, these
data demonstrate that SRPK1 and 2 have identical bio-
chemical properties in phosphorylating RS domain–con-
taining splicing factors in vitro, and support the idea that
SRPK2 is one of the kinases responsible for phosphorylat-
ing those splicing factors in vivo.
 
Selection of Preferred Substrates
 
The above biochemical characterization demonstrates that
the SRPK family members are highly specific for RS do-
main–containing splicing factors. To further define the
substrate specificity and understand the structural basis
for phosphorylation-site selection by the SRPK family of
kinases, we took a peptide selection approach that has
been developed to determine the substrate specificity of
protein kinases (Songyang et al., 1994, 1996). The method
involves phosphorylating a random peptide library using a
purified kinase followed by quantitative separation and
isolation of phosphopeptides, and then sequencing of the
Figure 2. Biochemical characterization of SRPK2. (A) In vitro
translated SRPK1 (lane 1) and SRPK2 (lane 2) were immunopre-
cipitated with anti-FLAG antibody followed by kinase assay on
beads using bacterial GST-ASF/SF2 as substrate (lanes 3 and 4).
In vitro translated and precipitated kinases (35S-labeled) and
phosphorylated GST-ASF/SF2 (32P-labeled) are indicated on the
right. (B) Phosphorylation of purified RS domain–containing
proteins (z0.1 mg each) by SRPK2. (C) Phosphorylation of a
panel of ASF/SF2 mutants (z1 mg each) by SRPK2. These mu-
tants were described by Caceres and Krainer (1993) and used in
our previous characterization of SRPK1 (Gui et al., 1994b) and
Clk/Sty (Colwill et al., 1996b). Residual phosphorylation in the
RT and RG mutant proteins likely occurred outside the mu-
tagenized region as discussed previously (Gui et al., 1994b). (D)
SRPK2-mediated phosphorylation restored the mAb104 phos-
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selected phosphopeptide pool. Amino acid(s) enriched in
a given position will indicate a preference for this amino
acid at that position in substrate recognition and phosphor-
ylation. Because the SRPK family members phosphorylate
RS domain–containing splicing factors, they are likely to
be arginine-directed kinases (Songyang et al., 1996). There-
fore, we chose a biased library in which serine was placed
at position 0, and arginine at position 23 (Fig. 3 A). Puri-
fied SRPK2 was used to phosphorylate the peptide library.
After quantitative removal of unphosphorylated peptides
by iron-chelating chromatography, SRPK2-phosphorylated
peptides were sequenced. Preferred amino acids at each
position are presented in Fig. 3 B. Although the experi-
ment was done using SRPK2, it is reasonable to assume
that the data are representive of the SRPK family of ki-
nases because both SRPK1 and 2 are highly related, dis-
playing very similar kinase activity and substrate specific-
ity as described above.
As shown in Fig. 3 B, SRPK2 generally prefers arginine,
but not lysine, near the phosphorylation site, which is con-
sistent with the fact that both SRPK1 and 2 phosphorylate
SR proteins, but not the KS mutant of ASF/SF2 (Fig. 2).
Besides arginine, SRPK2 also selected histidine NH2-ter-
minal of the serine. These observations suggest that the ki-
nase may require positive charges on both sides of the
serine, indicating that arginine-serine-arginine (RSR) is
the best substrate for the kinase. Based on these selection
data in combination with the mutagenesis results, it ap-
pears that phosphorylation mediated by the SRPK family
of kinases requires three criteria: (a) SR and RS dipep-
tides are preferred; (b) A basic environment around the
SR or RS dipeptide is critical; and (c) Lysine is not al-
lowed, especially at the 22 position (Fig. 2 C and Fig. 3 B).
These criteria explain why the SRPK family of kinases
could not phosphorylate most common kinase substrates
including histone H1 and myelin basic proteins (many con-
tain lysines and hydrophobic amino acids around phos-
phorylation sites). Further, one may use these criteria to
predict potential SRPK phosphorylation sites in a candi-
date protein substrate (see Discussion).
There are two notable exceptions to RSR as the best
substrate in the selection. First, proline was also preferen-
tially selected at the 11 position (compared to other posi-
tions). This finding explains the previous observation that
SRPK1 could phosphorylate the SPRY peptide in ASF/
SF2 in vitro (Colwill et al., 1996b). However, a synthetic
SPRY peptide was not a good substrate for SRPK1 (Col-
will et al., 1996b), likely due to the lack of surrounding ba-
sic amino acids. Second, both polar (N and Q) and acidic
(D and E) amino acids are significantly selected at the 22
position. This observation implies that the kinase may
phosphorylate an SRSR-containing peptide, regardless of
whether the first serine is unmodified (polar) or phosphor-
ylated (acidic; note that serine was not included in ran-
domized positions in the library so that its selection was
not detected). Therefore, the SRPK family of kinases may
be capable of phosphorylating both unphosphorylated and
partially phosphorylated SR proteins.
Structural Basis for Substrate Specificity
Perhaps the most striking feature of the SRPK family of
kinases is the strong selection of arginine at the P11 posi-
tion, which is in contrast to most protein kinases character-
ized so far (Songyang et al., 1994, 1996). Previous struc-
tural studies have revealed a pocket (called the P11
pocket) in the kinase catalytic core that is specific for se-
lecting the amino acid at the P11 position in the substrate.
Previous studies have established that the composition of
the P11 pocket is highly predictive of substrate specificity
(Songyang, Z., unpublished results). To understand the
mechanism for the P11 selection by the SRPK family
members, we aligned SRPK sequences with a number of
kinases whose tertiary structures have been determined,
and therefore the composition of their P11 pockets is
known (the sequence alignment of SRPK1 and 2 with
PKA is shown in Fig. 1 B). The sequence comparison re-
vealed identical P11 pockets for SRPK1 and 2, which is
consistent with identical substrate specificity between the
two kinases, and provides a rationale for the selection of
arginine at the P11 position, as described below.
At positions marked in Fig. 1 B and summarized in Fig.
4, the P11 pockets for PKA and many other kinases (their
Figure 3. Substrate specificity of SRPK2 determined by peptide
selection. (A) The serine-oriented and arginine-directed peptide
library used in this study. M 5 Met, A 5 Ala, K 5 Lys, and X 5
any amino acid except Ser, Thr, Cys, and Trp. The exclusion of
Ser and Thr in the library was to ensure phosphorylation at the
single serine residue, and omission of Cys and Trp was to avoid
problems with sequencing and oxidation. Positions relative to the
serine residue are indicated. (B) Each panel shows the relative
abundance of amino acids at each position, which is indicated in
the upper right corner.Wang et al. A New SR Protein Kinase 743
sequences not shown, see Hanks and Quinn, 1991) are
composed of hydrophobic residues, explaining the prefer-
ence of hydrophobic residues at the P11 position in both
selected and natural substrates (Songyang et al., 1994). In
contrast, previous modeling predicted that the arginine in
mitogen-activated protein kinase (MAPK) at the PKA 205
equivalent position sits in the bottom of the P11 pocket
and directly interacts with a secondary amine group in the
substrate (Songyang et al., 1994). Proline was strongly se-
lected by MAPK at the P11 position because it is the only
natural amino acid that has a secondary amine. For a simi-
lar reason, perhaps, proline was selected (although to a
lesser extent) by SRPK2 as the kinase also has an arginine
at this position (Arg550 in SRPK2, see Fig. 1 B and Fig. 4).
Casein kinase IIa (CKIIa) has a highly basic P11 pocket
including an arginine at the PKA equivalent position 198,
which is consistent with its selection for an acidic residue
at the P11 position in the substrate as explained earlier
(Songyang et al., 1996). In contrast, the P11 pocket of
both SRPK1 and 2 contains conserved polar (Asn532 in
SRPK2, which corresponds to Phe187 in PKA) and acidic
(Asp543, which corresponds to Leu198 in PKA) residues.
This acidic amino acid in the P11 pocket of these kinases
may be responsible for strong selection of arginine in the
P11 position in the substrate.
As described in the Introduction, Clk/Sty is capable of
phosphorylating SR proteins; however it can also phos-
phorylate many other substrates which do not contain any
RS motif (Colwill et al., 1996a,b). Sequence alignment re-
vealed that the P11 pocket of Clk/Sty (Fig. 4) is similar to
that of MAPK, explaining why Clk/Sty can phosphorylate
the SPRY peptide more efficiently than SRPK1 (Colwill
et al., 1996b). Further, a polar serine (Ser327 in Clk/Sty) at
the PKA equivalent position 187 may be partially respon-
sible for the selection of arginine at the P11 position. This
may be functionally significant as this serine residue is
conserved among all three Clk/Sty family members from
both mouse and human (Hanes et al., 1994). One may fur-
ther speculate that the phosphorylation specificity of Clk/
Sty for RS domain–containing splicing factors may be reg-
ulated by its own phosphorylation, thereby converting this
polar amino acid (Ser327) to a negatively charged residue
(phosphoserine). Clk/Sty may be autophosphorylated
(Johnson and Smith, 1991; Ben-David et al., 1991) or phos-
phorylated by other kinases, but the phosphorylation
site(s) remains to be determined and the postulated func-
tion and regulation of the serine residue in the P11 pocket
in the determination of substrate specificity will have to be
proven by mutagenesis.
The SRPK Family of Kinases Mediates
In Vitro Interactions between SR Domain–containing 
Splicing Factors
The biochemical data strongly suggest a role of SRPK1
and 2 in splicing. Recently, it was demonstrated that Clk/
Sty–mediated phosphorylation of ASF/SF2 facilitates its
interaction with another RS domain–containing splicing
factor, U1 70K (Xiao and Manley, 1997). To determine
whether the SRPK family of kinases has a similar function,
we tested the effect of SRPK1- and 2-mediated phosphor-
ylation on protein–protein interactions by the GST-pull-
down assay. Bacterially produced ASF/SF2 was efficiently
phosphorylated by either kinase, resulting in a marked
mobility shift in SDS-PAGE (Fig. 5 A), and phosphory-
lated ASF/SF2 interacted with in vitro translated U1 70K
much more efficently than the mock-phosphorylated pro-
tein (Fig. 5 B). GST alone did not bring down any U1 70K,
demonstrating the specificity of the assay. These data sup-
port a role for the SRPK family of kinases in spliceosome
assembly by facilitating specific protein–protein interac-
tions among spliceosomal components.
Localization of SRPK1 and SRPK2 and Evidence for 
Their Interaction with Splicing Factors In Vivo
It is known that splicing factors are concentrated in a
speckled pattern in the nucleus, yet splicing takes place
cotranscriptionally on nascent transcripts (for review see
Spector, 1993). Thus, splicing factors must be recruited to
sites of transcription and splicing (Jimenez-Garcia and
Spector, 1993; Huang and Spector, 1996; Misteli and Spec-
tor, 1997). Previous studies showed that kinases, such as
SRPK1 (Gui et al., 1994a) and Clk/Sty (Colwill et al.,
1996a), were able to induce the redistribution of splicing
factors from nuclear speckles to the nucleoplasm, indicat-
ing that these kinases may play an active role in the re-
cruitment process. To provide further evidence that the
SRPK family members interact with their substrates in
vivo and mediate the localization of splicing factors in the
nucleus, we determined the localization of both SRPK1
and 2 by peptide tagging or fusing to green fluorescent
protein (GFP), and examined the effect of overexpression
of these kinases on the localization of endogenous splicing
factors.
Previous studies showed that Clk/Sty is localized in the
nucleus, consistent with its function in splicing (Colwill et al.,
1996a). As shown in Fig. 6, we also detected both SRPK1
and 2 in the nucleus. Surprisingly, both these kinases are
Figure 4. Composition and comparison of P11 pockets. The
pocket composition for PKA, MAPK, and CK2a and preferred
amino acids in the P11 position of their substrates are from
Songyang et al. (1996). The assignment of amino acids that form
the P11 pockets for SRPK1 and 2 is based on the sequence align-
ment shown in Fig. 1 B, and the selected amino acids for SRPK2
are from Fig. 3 B. The deduced P11 pocket for Clk/Sty is also
based on a similar sequence alignment with kinases whose ter-
tiary structures have been determined (not shown). The subdo-
main locations of individual amino acids in the P11 pocket and
their positions corresponding to those of PKA are indicated.The Journal of Cell Biology, Volume 140, 1998 744
also found in the cytoplasm. Among transfected cells,
some displayed predominant cytoplasmic (Fig. 6, a and d),
whereas others displayed nuclear (Fig. 6, b and e) localiza-
tion. This heterogeneous pattern could be attributed to the
level of the expressed kinases, the physiological state of
the cell, or fixation and permeabilization conditions during
immunolocalization. To examine the localization of the
expressed kinases without fixation and permeabilization,
we directly visualized GFP-SRPK1 (Fig. 6 c) and GFP-
SRPK2 (Fig. 6 f) in living cells. The cytoplasmic signal ap-
pears to be predominant (Fig. 6, c and f), although the ex-
pressed kinases are also clearly visible in the nucleus (see
below for further details). Therefore, it is likely that the
endogenous kinases are present in both cellular compart-
ments.
The localization of the SRPK family of kinases in the cy-
toplasm is interesting because many kinases with a nuclear
function are regulated by nuclear translocation. In fact,
Dsk1, an SRPK family member from fission yeast, was
also found to localize predominantly in the cytoplasm in
interphase, but in the nucleus during mitosis (note that the
yeast nuclear envelope does not break down in mitosis;
Takeuchi and Yanagida, 1993). Thus, only a fraction of
these kinases may be required for splicing in the nucleus in
interphase, but a maximal level of such kinases may be
necessary for the reorganization of the splicing machinery
during mitosis, as suggested previously (Gui et al., 1994a).
Our studies, however, do not preclude the possibility that
the SRPK family of kinases has a function in the cyto-
plasm. We further observed that SRPK1 and more clearly
SRPK2 are not diffusely localized in the cytoplasm (Fig. 6,
a, d, and g). Instead, they appear to be attached to some
structure, which may function by anchoring these kinases
in the cytoplasm. We are currently determining the se-
quence requirements for the localization of both kinases in
the cytoplasm as well as in the nucleus.
Upon a close inspection of transfected cells, a punctate
nuclear population of both kinases was occasionally seen
in both fixed and living cells (see Fig. 6 c, for an example).
When focused on different focal planes (compare Fig. 6, g
and h), SRPK2 was clearly colocalized with B1C8 (Fig. 6,
h–j), a novel RS domain–containing splicing factor (Blen-
cowe and Sharp, personal communication) previously
characterized as one of the markers for nuclear speckles
(Blencowe et al., 1994). Similarly, we also detected colo-
calization of GFP-SRPK1 with SC35 in nuclear speckles
(data not shown). These observations suggest that at least
some fraction of SRPK1 and 2 interacts with their sub-
strates in the nucleus.
In most SRPK-transfected cells, images of nuclear
speckles appear diffused, a situation reminiscent of over-
expression of wild-type Clk/Sty (Colwill et al., 1996a). In
fact, this effect may reflect the movement of splicing fac-
tors mediated by the SRPK and Clk/Sty families of kinases
in the nucleus (for review see Fu, 1995). As shown in Fig.
7, overexpression of both SRPK1 (Fig. 7, a and b) and
SRPK2 (Fig. 7, e–h) effectively induced the redistribution
of endogenous splicing factors from nuclear speckles to
nucleoplasm. Splicing factors, such as the B1C8 antigen
(Fig. 7 b) and SR proteins detected by mAb104 (data not
shown), are concentrated in nuclear speckles in untrans-
fected cells, but became diffusely localized in cells overex-
pressing SRPK1. Similar results were also obtained with
SRPK2 (Fig. 7, e–h). In contrast, overexpression of a mu-
tant SRPK1, which contains a point mutation (K109M) at
the ATP-binding site and was previously shown to be an
inactive kinase (Colwill et al., 1996b), had little effect on
the distribution of endogenous SR proteins (Fig. 7, c and d).
These data are consistent with our published results that
application of purified SRPK1 onto permeabilized cells in
vitro induced the disassembly of the speckled nuclear do-
mains (Gui et al., 1994a), and strongly suggest that SRPK
family members are directly involved in releasing SR pro-
teins from nuclear speckles to the nucleoplasm. This may
represent an essential step in recruiting splicing factors to
nascent transcripts for cotranscriptional splicing suggested
by Spector and his colleagues (Jimenez-Garcia and Spec-
tor, 1993; Huang and Spector, 1996; Misteli and Spector,
1997).
Finally, other nuclear structures, such as the PML onco-
Figure 5. In vitro protein–protein interaction enhanced by
SRPK-mediated phosphorylation. Bacterial GST-ASF/SF2 was
phosphorylated by SRPK1 (lane 4) or SRPK2 (lane 6) or mock-
phosphorylated (lanes 3 and 5). In vitro translated U1 70K (lane
1, total input in each binding assay) was incubated with beads
coupled with GST or treated GST-ASF/SF2. Bound proteins
were resolved in a 10% SDS-PAGE followed by autoradiogra-
phy. (A) Coomassie blue staining of total (lane 1) and bound pro-
teins (lanes 2–6). Note that phosphorylated GST-ASF/SF2 dis-
played a marked mobility shift. (B) An autoradiograph of the
same protein gel. U1 70K was not retained by GST (lane 2), but
bound to some extent to mock-phosphorylated GST-ASF/SF2
(lanes 3 and 5) and efficiently to phosphorylated GST-ASF/SF2
by SRPK1 (lane 4) and SRPK2 (lane 6).Wang et al. A New SR Protein Kinase 745
genic domains (Dyck et al., 1994) detected by the anti-
PML mAb5E10 (Stuurman et al., 1992) and nuclear enve-
lope detected by anti-lamine A/C antibodies (Gui et al.,
1994a), were not affected by overexpression of either
SRPK1 or 2 (Fig. 7, i–l). Therefore, the SRPK family of ki-
nases appears to specifically mediate the redistribution of
splicing factors in the nucleus.
SR Protein Kinases Are Differentially Expressed
Current data suggest that both the Clk/Sty and SRPK fam-
ilies of kinases are involved in the regulation of spliceo-
some assembly by mediating the localization and interac-
tion of splicing factors in mammalian cells. It is, however,
unlikely that they are completely redundant kinases, as
each kinase may have a more defined spectrum of sub-
strates. Alternatively, these kinases may be differentially
expressed and/or regulated. To explore these possibilities,
we examined the expression of these SR protein kinases
by Northern blotting analysis in multiple human tissues as
well as in many commonly used experimental cell lines. As
shown in Fig. 8, SRPK1 and 2 are expressed as single 4.4-
and 4.3-kb transcripts, respectively, in multiple human tis-
sues. SRPK1 is highly expressed in pancreas whereas
SRPK2 is highly expressed in brain. Both kinases are mod-
erately expressed in other tissues including heart and skel-
etal muscle and the expression of both is low in lung, liver,
and kidney. These results clearly show that SRPK1 and 2
are differentially expressed, which may contribute to the
tissue specific regulation of both constitutive and alterna-
tive splicing.
In 11 experimental human cell lines examined, SRPK1
and 2 are ubiquitously expressed, although with notable
differences (Fig. 8, C and D). Compared to their expres-
sion in HeLa cells after normalizing against GAPDH,
SRPK1 is expressed at a higher level than SRPK2 in Weri-1
and Lan5, but much lower in Soas2 cells, and both kinases
exhibit a low level of expression in two leukemia cell lines,
THP1 and U937. Clk/Sty is expressed as two transcripts
(3.2 and 1.8 kb) resulting from alternative splicing as char-
acterized previously (Duncan et al., 1995). The 1.8-kb tran-
script corresponds to the primary cDNA for the active ki-
nase, whereas the 3.2-kb mRNA results from a partially
spliced RNA, and therefore does not encode a functional
kinase (Duncan et al., 1995). Interestingly, the 1.8-kb mes-
sage is ubiquitously expressed, whereas the expression of
the 3.2-kb RNA is cell specific (Fig. 8 E, lane 3, for exam-
ple), indicating that Clk/Sty may be regulated by alterna-
tive splicing in a cell specific fashion. These results will
guide us in choosing a cellular model to study the regula-
tion of splicing by specific kinases in the future. Together,
these data demonstrate that SR protein kinases are differ-
entially expressed. Thus, various SR protein kinases may
be regulated at multiple levels by differential expression,
alternative splicing, nuclear translocation, phosphoryla-
tion activation, or suppression, etc. These multiple regula-
tion pathways in combination with their distinct substrate
specificity likely contribute to the complexity of regulation
of alternative splicing in mammalian cells and tissues, in
response to signaling, or during development.
Discussion
Expression of Multiple SR Protein Kinases in 
Mammalian Cells
Two families of SR protein kinases (Clk/Sty and SRPK)
are now well characterized. The Clk/Sty family has three
members (Hanes et al., 1994) and the SRPK family has
Figure 6. Localization of
SRPK1 and SRPK2 in trans-
fected HeLa tTA cells.
FLAG-tagged SRPK1 (a and
b) and SRPK2 (d and e) are
localized in both the cyto-
plasm (represented in a and
d) and the nucleus (repre-
sented in b and e). Predomi-
nant cytoplasmic signal was
seen with GFP-SRPK1 (c)
and GFP-SRPK2 (f), al-
though some punctate nu-
clear population was visible
(see c, for example). When
viewed in different focal
planes, signals in both the cy-
toplasm (g) and the nucleus
(h) were evident, and the nu-
clear population (h) colocal-
ized with the B1C8 antigen
(i), a marker for nuclear
speckles. A merged image
appears yellow (j).The Journal of Cell Biology, Volume 140, 1998 746
two. Chromosome mapping suggests that the SRPK1 locus
is situated on mouse chromosome 17 and human chromo-
some 6, and SRPK2 on mouse chromosome 5 and human
chromosome 7, respectively (Wang, H.-Y., J.B. Berming-
ham, W. Lin, K.C. Arden, and X.-D. Fu, manuscript in
preparation). In addition, probes derived from the con-
served kinase domains detected additional loci in mouse
chromosome X and human chromosome 8 and 18 (our un-
published results), indicating that these loci may encode
additional SRPK family members or pseudogenes. Consis-
tent with this prediction, a cDNA fragment (named
WBP6) was recently isolated from a mouse library in a
two-hybrid screen, which resembles the human SRPK2
(Bedford et al., 1997). The isolated partial cDNA has the
coding capacity for proline-rich and kinase domains nearly
identifical to the corresponding domains in SRPK2. How-
ever, the partial clone lacks NH2 terminal sequence, and
the reported NH2 terminal part is completely different
from that of SRPK2. Thus, it remains unclear whether the
isolated cDNA represents the mouse homologue of hu-
man SRPK2 or another highly related kinase.
Kinases responsible for phosphorylation of RS domain–
containing splicing factors may not be confined to the two
families described above. Previous work showed that PKA
and protein kinase C can phosphorylate ASF/SF2 in vitro
(Colwill et al., 1996a), although the functional significance
of these phosphorylation events remains unclear. In addi-
tion, the NimA kinase selects arginines on both sides of
serine, suggesting that this kinase may also be involved in
phosphorylating SR proteins (Songyang et al., 1996). Con-
sistent with this possibility, a catalytically mutant form of
this kinase has been shown to colocalize with splicing fac-
tors in nuclear speckles (Lu et al., 1996). However, unlike
SRPK2, NimA stringently requires a phenylalanine at the
23 position (Songyang et al., 1996), indicating that the ki-
nase may, at most, phosphorylate only a subset of SR pro-
teins. NimA functions as a cell cycle regulator (Lu and
Hunter, 1995), but whether or not it also has a role in splic-
ing and is capable of phosphorylating some SR proteins
remain to be verified in future studies.
Structural Basis for the Activity and Specificity of the 
SRPK Family of Kinases
Recombinant SRPK1 and 2 are highly active and specific,
indicating that these kinases may have an open conforma-
tion for substrate recognition and catalysis. Although the
crystal structure of these kinases remains to be elucidated,
comparison with PKA revealed a basis for substrate speci-
ficity in the P11 pocket as described in Results. In addi-
tion, the insertion in the linker loop within kinase domain
V (Fig. 1 B) may contribute to the separation between the
small and large lobes, and thus, to an open conformation
of the SRPK family of kinases for substrate recognition
and orientation. In PKA, Thr197 in the activation loop is
consititutively phosphorylated upon synthesis and the
phosphate on Thr197 is highly resistant to hydrolysis by
phosphatase (Steinberg et al., 1993). According to the
PKA crystal structure, this phosphothreonine forms ion
pairs with His87 in the small lobe, and Arg165 and Lys189
in the large lobe, and these interactions are postulated to
be critical for the conformation of the active site in the en-
zyme (see discussion by Taylor and Radzio-Andzelm,
1994). The salt bridge between His87 and phosphothre-
Figure 7. Specific induction
of redistribution of endoge-
nous splicing factors by over-
expression of SRPK1 and
SRPK2. The B1C8 antigen
(b,  d, and f) and SR proteins
(h) stained with mAb104 are
concentrated in nuclear speck-
les of untransfected cells. Over-
expression of FLAG-tagged
SRPK1 (a) and SRPK2 (e and
g) induced the redistribution
of both the B1C8 antigen (b
and f) and SR proteins (h)
from speckles to the nucleo-
plasm. Overexpression of in-
active SRPK1 had little effect
on SR protein localization (c
and d). Reduced signal in ki-
nase-expressed cells likely
reflects some loss of solubi-
lized splicing factors during
fixation and permeabilization.
In contrast, overexpression of
FLAG-tagged SRPK2 (i and
k) had no effect on the struc-
tural integrity of PML-posi-
tive PODs detected by 5E10
(j) or the nuclear envelope
stained with anti-lamine anti-
bodies (l).Wang et al. A New SR Protein Kinase 747
onine197 is at least partially responsible for the closed
conformation of PKA (Knighton et al., 1991), and the in-
teraction is broken for the open conformation of the en-
zyme (Zheng et al., 1993). As discussed earlier regarding
the structural features of Clk/Sty and SRPK1 (Colwill et
al., 1996a), these two families of kinases have a completely
different set of amino acids in the corresponding positions.
As illustrated in Fig. 1 B, Thr197 in PKA is replaced by a
glutamic acid residue in both SRPK1 and 2; it is unclear
which amino acid corresponds to His87 as the region in ki-
nase domain III contains a small, but critical deletion in
both SRPK1 and 2; and Arg165 and Lys189 are replaced
by threonine and cysteine, respectively. These differences
suggest that SRPK1 and 2 as well as Clk/Sty may have a
very different conformation than PKA at their active sites,
which may explain why these two families of kinases are
both highly active and selective in phosphorylating RS do-
main–containing splicing factors.
Proline-rich Domain in SRPK2
Characterization of the second SRPK family member not
only illustrates the complexity of regulation of splicing fac-
tors by multiple kinases, but also implies potential regula-
tion of the kinase itself. One interesting structural feature
of SRPK2 is its NH2 terminal proline–rich domain, which
contains several consensus binding sites for an SH3 do-
main (Ren et al., 1993). To explore potential regulation of
splicing by signaling, we are currently testing whether
SRPK2 is associated with any SH3 domain–containing
proteins. The proline-rich sequences are also frequent
binding targets for WW domain–containing proteins (Chen
and Sudol, 1995; Chan et al., 1996; Macias et al., 1996; Su-
dol, 1996b). Indeed, it was recently shown that a formin-
binding protein interacts with a SRPK2-like kinase (WBP6)
from mouse in a two-hybrid screen (Bedford et al., 1997).
Whether this association is of functional significance remains
to be investigated. The WW domain is present in a grow-
ing number of structural, regulatory, and signaling mole-
cules (see an automatic update of WW domain–containing
proteins under the following electronic address: http://
www.brok.embl-heidelberg.de/Modules/ww-gif.html; Sudol
et al., 1996a). Some splicing factors, such as Prp40 from
yeast, also contain this domain (Kao and Siliciano, 1996).
Therefore, it will be interesting to investigate whether the
NH2 terminal proline–rich domain in SRPK2 interacts
with WW domain proteins, especially WW domain–con-
taining splicing factors. Such interactions may contribute
to a unique substrate specificity, regulation and/or cellular
targeting of the kinase in mammalian cells.
Implication of Nuclear and Cytoplasmic Localization of 
the SRPK Family of Kinases
The SRPK family of kinases is characterized by a large
spacer sequence dividing conserved catalytic kinase do-
mains into two halves. Structural modeling of both kinases
suggests that the spacers constitute a unique domain,
which may function autonomously. This structural ar-
rangement is rare among serine/threonine kinases, but
common in tyrosine kinases. For example, upon PDGF
binding on the cell surface, the PDGF receptor becomes
phosphorylated in its spacer, which then serves as a plat-
form for signal relay by interacting with adaptor molecules
(for review see Ullrich and Schlessinger, 1990). By such an
analogy, the spacer sequences may also influence the bio-
logical function of SRPKs in mammalian cells.
A clue to the role of these spacer sequences comes from
the observation that deletion of the spacer from Dsk1, a
SRPK family member from fission yeast, resulted in exclu-
sive nuclear localization of the mutant kinase in interphase
cells (Takeuchi and Yanagida, 1993). A similar phenome-
non was also seen with both SRPK1 and 2 (our unpub-
lished results). Thus, the spacer sequences may be in-
Figure 8. Northern blotting
analysis of SR protein ki-
nases (indicated in the right
of each panel) in multiple hu-
man tissues (A and B) and
cell lines (C–E).The Journal of Cell Biology, Volume 140, 1998 748
volved in the regulation of nuclear translocation of these
SR protein kinases.
As shown above, SRPK1 and 2 are present in the nu-
cleus and cytoplasm. The localization of these kinases in
the nucleus is consistent with their putative function in
splicing. The significance of their presence in the cyto-
plasm is unclear, but might reflect additional functions of
these kinases in the cytoplasm. Alternatively, a fraction of
these kinases may be restricted to the cytoplasm because
oversupply of these kinases can completely alter the orga-
nization of the splicing machinery in the nucleus, and
therefore, may be detrimental to normal cell physiology.
We observed that both SRPK1 and 2 are localized in the
cytoplasm in a nondiffused fashion, although the underly-
ing cytoplasmic structure remains to be characterized.
These findings, taken together with the observations that
SRPK1 and 2 become exclusively localized in the nucleus
after their spacers are removed (our unpublished observa-
tions), suggest that these kinases may be anchored in the
cytoplasm through their spacer sequences.
Rules to Predict Preferred Phosphorylation Sites for the 
SRPK Family of Kinases
Our peptide selection studies have provided a structural
basis to explain the stringent substrate specificity observed
with the SRPK family of kinases. This information can
also be used to predict potential kinase substrates. As de-
scribed in Results, these kinases appear to prefer phosphor-
ylating an SR or RS dipeptide in a basic environment en-
riched with arginine or histidine, but not lysine. This rule
applies to all proven substrates tested so far in our lab. For
example, all standard SR proteins satisfy such a rule and
they can be efficiently phosphorylated by either SRPK1 or
2 in vitro. We also tested phosphorylation of other RS do-
main–containing splicing factors, such as human U2AF65
(Zamore et al., 1992) and U2AF35 (Zhang et al., 1992),
and their homologues from Drosophila (dU2AF50 and
dU2AF38; Kanaar et al., 1993; Rudner et al., 1996) and fis-
sion yeast (Prp2; Potashkin et al., 1993). All these RS do-
main–containing splicing factors contain multiple SR or
RS dipeptides and are phosphorylated by SRPK1 (our un-
published observations).
It should be emphasized that not all RS domain–con-
taining proteins implicated in splicing are substrates for
SRPK1 or 2. For example, Clk/Sty contains 10 SR or RS
repeats at the NH2 terminus (Ben-David et al., 1991).
However, it could not be phosphorylated in vitro by SRPK1
(our unpublished result), and inspection of its RS domain
indicates that none of those dipeptides satisfies the criteria
for recognition and phosphorylation by SRPK1 and 2 as
described above. In addition, Snp1p, a U1 70-K homo-
logue from yeast, contains a number of dispersed SR or
RS dipeptides (Smith and Barrell, 1991). Again, none of
those dipeptides is surrounded by arginine or histidine,
and Snp1p could not be phosphorylated by SRPK1. In
contrast, the B1C8 antigen, which was initially identified
by an antinuclear matrix monoclonal antibody (Blencowe
et al., 1994), was found to be a good substrate for SRPK1
during its biochemical purification, and recent cloning and
characterization show that it is an RS domain–containing
splicing factor (Blencowe et al., 1998). Finally, we have re-
cently cloned and characterized a novel splicing factor,
which is a U2AF35-related protein called Urp in a two-
hybrid screen using SRPK1 as bait (Tronchere et al.,
1997). Urp contains a typical RS domain at the COOH ter-
minus and the protein was an excellent substrate for
SRPK1. Therefore, the stringent substrate specificity and
the sequence requirement defined by peptide selection
may be used to identify additional RS domain–containing
proteins that may have a role in splicing.
How SR Protein Kinases May Affect Splicing
It was recently reported that Clk/Sty facilitates SR pro-
tein–protein interactions and prevents nonspecific pro-
tein–RNA interactions (Tacke and Manley, 1997; Xiao
and Manley, 1997). In this paper, we show that the SRPK
family of kinases has an analogous function in promoting
SR protein–protein interactions. Thus, it is conceivable
that multiple kinases are involved in splicing in mamma-
lian cells. However, the function of these SR protein ki-
nases in splicing is just beginning to be understood. Previ-
ous studies using phosphatase inhibitors indicate that
phosphorylation of SR proteins is required for spliceo-
some assembly, and thus, SR protein kinases can be con-
sidered as activators for SR proteins (Mermoud et al.,
1994). However, subsequent dephosphorylation is also im-
portant for splicing as blocking dephosphorylation by
phosphatase inhibitors prevented splicing from occurring
in the fully assembled spliceosome (Mermoud et al., 1994).
In agreement with this finding, we observed that too much
SRPK1 is also inhibitory to splicing, likely by interfering
with dephosphorylation in a later step of the splicing reac-
tion (Gui et al., 1994a). These observations are consistent
with the idea that the level of SR protein kinases in the nu-
cleus must be regulated.
SR proteins are known to affect splice-site selection
both in vitro and in vivo, and, as such, it seems likely that
SR protein kinases might affect alternative splicing. Ear-
lier studies demonstrated that SR proteins generally stim-
ulate the selection of the proximal 59 and 39 splice sites if
two competing splice sites contain identical splicing signals
(Fu et al., 1992). This situation, however, is unlikely to be
the case in most natural alternative splicing systems. In the
SV-40 T/t alternative splicing system, for example, differ-
ent SR proteins were shown to prefer different splice sites
(Zahler et al., 1993). Therefore, selection of a specific
splice site may be dictated by combinatory actions and
competition of mutiple SR proteins and other splicing fac-
tors. For this reason, it will be difficult to predict which di-
rection a specific alternative splicing event will follow after
the activation of multiple SR proteins by a specific SR pro-
tein kinase. A specific alternative splicing event may be
regulated by the expression of a unique spectrum of SR
proteins, which may in turn be regulated by kinases with
distinct activity and substrate specificity. The identifica-
tion of additional SR protein kinases will ultimately con-
tribute to an understanding of regulatory events governing
alternative splicing.
We thank Susan Taylor of University of California at San Diego (UCSD;
La Jolla, CA) (UCSD) for many useful discussions on kinase structure
and function, and Marius Sudol (Mount Sinai School of Medicine, New
York) for many stimulating discussions. We are grateful to B. BlencoweWang et al. A New SR Protein Kinase 749
and P. Sharp (Massachusetts Institute of Technology, Cambridge, MA)
for B1C8 antibody, L. De Jong (University of Amsterdam) for the 5E10
anti-PML antibody, D. Black (University of California, Los Angeles, Los
Angeles, CA) for Weri-1 and Lan5 cell lines, C. Glass (UCSD) for U937
and THP1 cell lines, M. Kamps (UCSD) for HBL100 and HT1080 cell
lines, and J. Wang (UCSD) for Bosc23 and Soas2 cell lines. The authors
thank members of the Fu lab for cooperation and suggestions during the
course of this study, especially S. Chandler for help in SRPK2 expression
and purification, and L. Feng for help in immunohistochemistry.
J.A. Dyck and J.M. Yeakley are supported by fellowships from Damon
Runyon-Walter Winchell Foundation and National Institutes of Health
(NIH), respectively. X-D. Fu is a Leukemia Society of American Scholar.
This work was supported by a grant from NIH (GM52872) to X-D. Fu.
Received for publication 3 October 1997 and in revised form 21 Novem-
ber 1997.
References
Bedford, M.T., D.C. Chan, and P. Leder. 1997. FBP WW domains and the ABL
SH3 domains bind to a specific class of proline-rich ligands. EMBO (Eur.
Mol. Biol. Organ.) J. 16:2376–2383.
Ben-David, Y., K Letwin, L. Tamock, A. Bernstein, and T. Pawson. 1991. A
mammalian protein kinase with potential for serine/threonine and tyrosine
phosphorylation is related to cell cycle regulators. EMBO (Eur. Mol. Biol.
Organ.) J. 10:317–325.
Blencowe, B.J., J.A. Nickerson, R. Issner, S. Penman, and P.A. Sharp. 1994. As-
sociation of nuclear matrix antigens with exon-containing splicing com-
plexes.  J. Cell Biol. 127:593–607.
Blencowe, B.J., R. Issner, J.A. Nickerson, and P.J. Sharp. 1998. A coactivator of
pre-mRNA splicing. Genes Dev. In press.
Caceres, J.F., and A.R. Krainer. 1993. Functional analysis of pre-mRNA splic-
ing factor SF2/ASF structural domains. EMBO (Eur. Mol. Biol. Organ.) J.
12:4715–4726.
Cardinali, B., P.T. Cohen, and A.I. Lamond. 1994. Protein phosphatase 1 can
modulate alternative 59 splice site selection in a HeLa splicing extract. FEBS
Lett. 35:276–280.
Chan, D.C., M.T. Bedford, and P. Leder. 1996. Formin binding proteins bear
WWP/WW domains that bind proline-rich peptides and functionally resem-
ble SH3 domains. EMBO (Eur. Mol. Biol. Organ.) J. 15:1045–1054.
Chen, H.I., and M. Sudol. 1995. The WW of Yes-associated protein binds a pro-
line-rich ligand that differs from the consensus established for Src homology
3-binding modules. Proc. Natl. Acad. Sci. USA. 92:7819–7823.
Colwill, K., T. Pawson, B. Andrews, J. Prasad, J.L. Manley, J.C. Bell, and P.I.
Duncan. 1996a. The Clk/Sty protein kinase phosphorylates SR splicing fac-
tors and regulates their intranuclear distribution. EMBO (Eur. Mol. Biol.
Organ.) J. 15:265–275.
Colwill, K., L.L. Feng, J.M. Yeakaly, G.D. Gish, J.F. Caceres, T. Pawson, and
X-D. Fu. 1996b. SRPK1 and Clk/Sty protein kinases show distinct substrate
specifities for serine/arginine-rich splicing factors. J.Biol. Chem. 271:24569–
24575.
Duncan, P.I., B.W. Howell, R.M. Marius, S. Drmanic, E.M. Douville, and J.C.
Bell. 1995. Alternative splicing of STY, a nuclear dual specificity kinase. J.
Biol. Chem. 270:21524–21531.
Dyck, J.A., G.G. Maul, W.H. Miller, J.D. Chen, A. Kakizuka, and R.M. Evans.
1994. A novel macromolecular structure is a target of the promyelocyte-ret-
inoic acid receptor oncoprotein. Cell. 76:333–343.
Fu, X-D. 1995. The superfamily of arginine-serine-rich splicing factors. RNA.
1:663–680.
Fu, X-D., and T. Maniatis. 1990. Factor required for mammalian spliceosome
assembly is localized to discrete regions in the nucleus. Nature. 343:437–441.
Fu, X-D., A. Mayeda, T. Maniatis, and A.R. Krainer. 1992. General splicing
factors SF2 and SC35 have equivalent activities in vitro, and both affect al-
ternative 59 and 39 splice site selection. Proc. Natl. Acad. Sci. USA. 89:11224–
11228.
Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mamma-
lian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA.
89:5547–5551.
Gui, J-F., W.S. Lane, and X-D. Fu. 1994a. A serine kinase regulates intracellu-
lar localization of splicing factors in the cell cycle. Nature. 369:678–682.
Gui, J-F., H. Tronchere, S.D. Chandler, and X-D. Fu. 1994b. Purification and
characterization of a kinase specific for the serine-and arginine-rich pre-
mRNA splicing factors. Proc. Natl. Acad. Sci. USA. 91:10824–10828.
Hanes, J., H. von der Kammer, J. Klaudiny, and K.H. Scheit. 1994. Character-
ization by cDNA cloning of two new human protein kinases. Evidence by se-
quence comparison of a new family of mammalian protein kinases. J. Mol.
Biol. 244:665–672.
Hanks, S.K., and A.M. Quinn. 1991. Protein kinase catalytic domain sequence
database: identification of conserved features of primary and classification
of family members. Methods Enzymol. 200:38–62.
Howell, B.W., D.E. Afar, J. Lew, E.M. Douville, P.L. Icely, D.A. Gray, and J.C.
Bell. 1991. STY, a tyrosine-phosphorylating enzyme with sequence homol-
ogy to serine/threonine kinases. Mol. Cell. Biol. 11:568–572.
Huang, S., and D.L. Spector. 1996. Intron-dependent recruitment of pre-
mRNA splicing factors to sites of transcription. J. Cell Biol. 133:719–732.
Jimenez-Garcia, L.F., and D.L. Spector. 1993. In vivo evidence that transcrip-
tion and splicing are coordinated by a recruiting mechanism. Cell. 73:47–59.
Johnson, K.W., and K.A. Smith. 1991. Molecular cloning of a novel human
cdc2/CDC28-like protein kinase. J. Biol. Chem. 266:3402–3407.
Kanaar, R., S.E. Roche, E.L. Beall, M.R. Green, and D.C. Rio. 1993. The con-
served pre-mRNA splicing factor U2AF from Drosophila: requirement for
viability. Science. 262:569–573.
Kao, H.Y., and P.G. Siliciano. 1996. Identification of Prp40, a novel essential
yeast splicing factor associated with the U1 small nuclear ribonucleoprotein
particle. Mol. Cell. Biol. 16:960–967.
Knighton, D.R., J. Zheng, L.F. Ten Eyck, V.A. Ashford, N.H. Xuong, S.S. Tay-
lor, and J.M. Sowadski. 1991. Crystal structure of the catalytic subunit of
cAMP-dependent protein kinase. Science. 253:407–414.
Krämer, A. 1996. The structure and function of proteins involved in mamma-
lian pre-mRNA splicing. Annu. Rev. Biochem. 65:367-409.
Lu, K.P., and T. Hunter. 1995. Evidence for a NIMA-like mitotic pathway in
vertebrate cells. Cell. 81:413–424.
Lu, K.P., S.D. Hanes, and T. Hunter. 1996. A human peptidyl-prolyl isomerase
essential for regulation of mitosis. Nature. 380:544–547.
Macias, M.J., M. Hyvonen, E. Baraldi, J. Schultz, M. Sudol, M. Saraste, and H.
Oschkinat. 1996. Structure of the WW domain of a kinase-associated protein
complexed with a proline-rich peptide. Nature. 382:646–649.
Manley, J.L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev.
10:1569–1579.
Mermoud, J.E., P.T. Cohen, and A.I. Lamond. 1992. Ser/Thr-specific protein
phosphophatases are required for both catalytic steps pre-mRNA splicing.
Nucleic Acids Res. 20:5263–5269.
Mermoud, J.E., P.T. Cohen, and A.E. Lamond. 1994. Regulation of mamma-
lian splicesome assembly by a protein phosphorylation mechanism. EMBO
(Eur. Mol. Biol. Organ.) J. 13:5679–5688.
Misteli, T., and D.L. Spector. 1996. Serine/threonine phosphatase I modulates
the subnuclear distribution of pre-mRNA splicing factors. Mol. Biol. Cell.
7:1559–1572.
Misteli, T., J.F. Caceres, and D.L. Spector. 1997. The dynamics of a pre-mRNA
splicing factor in living cells. Nature. 387:523–527.
Potashkin, J., K. Naik, and K. Wentz-Hunter. 1993. U2AF homolog required
for splicing in vivo. Science. 262:573–575.
Ren, R., B.J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a
ten-amino acid proline-rich SH3 binding site. Science. 259:1157–1161.
Rudner, D.Z., R. Kanaar, K.S. Breger, and D.C. Rio. 1993. Mutations in the
small subunit of the Drosophila U2AF splicing factor cause lethality and de-
velopmental defects. Proc. Natl. Acad. Sci. USA. 93:10333–10337.
Smith, V., and B.G. Barrell. 1991. Cloning of a yeast U1 snRNP 70K protein
homologue: functional conservation of an RNA-binding domain between
humans and yeast. EMBO (Eur. Mol. Biol. Organ.) J. 10:2627–2634.
Songyang, Z., S. Blechner, N. Hoagland, M.F. Hoekstra, H. Piwnica-Worms,
and L.C. Cantley. 1994. Use of an oriented peptide library to determine the
optimal substrates of protein kinases. Curr. Biol. 4:973–982.
Songyang, Z., K.P. Lu, Y.T. Kwon, L.H. Tsai, O. Filhol, C. Cochet, D.A.
Brickey, T.R. Soderling, C. Bartleson, D.J. Graves, et al. 1996. A structural
basis for the substrate specifities of protein ser/thr kinases: primary sequence
preference of casein kinase I and II, NIMA, phosphorylase kinase, calmodu-
lin-dependent kinase II, CDK5 and Erk1. Mol. Cell. Biol. 16:6486–6493.
Spector, D.L. 1993. Macromolecular domains within the cell nucleus. Annu.
Rev. Cell. Biol. 9:265–315.
Steinberg, R.A., R.D. Cauthron, M.M. Symcox, and H. Shuntoh. 1993. Autoac-
tivation of catalytic (C alpha) subunit of cyclic AMP-dependent protein ki-
nase by phosphorylation of threonine 197. Mol. Cell. Biol. 13:2332–2341.
Stuurman, N., A. De Graof, A. Floore, A. Josso, B. Humbel, L. De Jong, and
R. Van Driel. 1992. A monoclonal antibody recognizing nuclear matrix-asso-
ciated nuclear bodies. J. Cell Sci. 101:773–784.
Sudol, M. 1996a. Structure and function of the WW domain. Prog. Biophys.
Mol. Biol. 65:113–132.
Sudol, M. 1996b. The WW module competes with the SH3 domain? Trends
Biochem. Sci. 21:161–163.
Sudol, M., H.I. Chen, C. Bougeret, A. Einbond, and P. Bork. 1995. Character-
ization of a novel protein-binding module-the WW domain. FEBS Lett. 369:
67–71.
Tacke, R., Y. Chen, and J.L. Manley. 1997. Sequence-specific RNA binding by
an SR protein requires RS domain phosphorylation: creation of an SRp40-
specific splicing enhancer. Proc. Natl. Acad. Sci. USA. 94:1148–1153.
Takeuchi, M., and M. Yanagida. 1993. A mitotic role for a novel fission yeast
protein kinase dsk1 with cell cycle stage dependent phosphorylation and lo-
calization. Mol. Biol. Cell. 4:247–260.
Taylor, S.S., and E. Radizo-Andzelm. 1994. Three protein kinase structures de-
fine a common motif. Structure. 2:345–355.
Tazi, J., U. Kornstadt, F. Rossi, P. Jeanteur, G. Cathala, C. Brunnel, and R. Lu-
hrmann. 1993. Thiophosphorylation of U1-70K protein inhibits pre-mRNA
splicing. Nature. 363:283–286.
Tronchere, H., J. Wang, and X-D. Fu. 1997. A protein related to splicing factor
U2AF35 that interacts with U2AF65 and SR proteins in splicing of pre-The Journal of Cell Biology, Volume 140, 1998 750
mRNA. Nature. 388:397–400.
Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with ty-
rosine kinase activity. Cell. 61:203–212.
Valcárcel, J., and M.R. Green. 1996. The SR protein family: pleiotropic func-
tions in pre-mRNA splicing. Trends Biochem. Sci. 21:296–301.
Xiao, S.H., and J.L. Manley. 1997. Phosphorylation of the ASF/SF2 RS domain
affects both protein-protein and protein-RNA interactions and is necessary
for splicing. Genes Dev. 11:334–344.
Zahler, A.M., W.S. Lane, J.A. Stolk, and M.B. Roth. 1992. SR proteins: a con-
served family of pre-mRNA splicing factors. Genes Dev. 6:837–847.
Zahler, A.M., K.M. Neugebauer, W.S. Lane, and M.B. Roth. 1993. Distinct
functions of SR proteins in alternative pre-mRNA splicing. Science. 260:
219–222.
Zamore, P.D., J.G. Patton, and M.R. Green. 1992. Cloning and domain struc-
ture of the mammalian splicing factor U2AF. Nature. 355:609–614.
Zhang, M., P.D. Zamore, M. Carmo-Fonseca, A.I. Lamond, and M.R. Green.
1992. Cloning and intracellular localization of the U2 small nuclear ribonu-
cleoprotein auxiliary factor small subunit. Proc. Natl. Acad. Sci. USA. 89:
8769–8773.
Zheng, J., D.R. Knighton, H.H. Xuong, S.S. Taylor, J.M. Sowadski, and L.F.
Ten Eyck. 1993. Crystal structures of the myristylated catalytic subunit of
cAMP-dependent protein kinase reveal open and closed conformations.
Protein Sci. 2:1559–1573.